Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ) has issued an update.
Mochida Pharmaceutical Co., Ltd. announced the approval of its Takeover Response Policy at its 87th Ordinary General Meeting of Shareholders. The company also resolved changes in its Special Committee members due to shifts in corporate officers, aiming to strengthen its governance and strategic direction.
More about Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products and services. The company is listed on the Prime Market and is represented by Naoyuki Mochida.
Average Trading Volume: 24,435
Technical Sentiment Signal: Sell
Current Market Cap: Yen99.98B
See more data about 4534 stock on TipRanks’ Stock Analysis page.